BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30074477)

  • 1. HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties.
    Abel EV; Goto M; Magnuson B; Abraham S; Ramanathan N; Hotaling E; Alaniz AA; Kumar-Sinha C; Dziubinski ML; Urs S; Wang L; Shi J; Waghray M; Ljungman M; Crawford HC; Simeone DM
    Elife; 2018 Aug; 7():. PubMed ID: 30074477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte nuclear factor 1A (HNF1A) as a possible tumor suppressor in pancreatic cancer.
    Luo Z; Li Y; Wang H; Fleming J; Li M; Kang Y; Zhang R; Li D
    PLoS One; 2015; 10(3):e0121082. PubMed ID: 25793983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HNF1A regulates colorectal cancer progression and drug resistance as a downstream of POU5F1.
    Fujino S; Miyoshi N; Ito A; Yasui M; Matsuda C; Ohue M; Uemura M; Mizushima T; Doki Y; Eguchi H
    Sci Rep; 2021 May; 11(1):10363. PubMed ID: 33990627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HNF1A regulates oxaliplatin resistance in pancreatic cancer by targeting 53BP1.
    Xia R; Hu C; Ye Y; Zhang X; Li T; He R; Zheng S; Wen X; Chen R
    Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36825600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of glutamine metabolism counteracts pancreatic cancer stem cell features and sensitizes cells to radiotherapy.
    Li D; Fu Z; Chen R; Zhao X; Zhou Y; Zeng B; Yu M; Zhou Q; Lin Q; Gao W; Ye H; Zhou J; Li Z; Liu Y; Chen R
    Oncotarget; 2015 Oct; 6(31):31151-63. PubMed ID: 26439804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HNF1A/CASC2 regulates pancreatic cancer cell proliferation through PTEN/Akt signaling.
    Yu Y; Liang S; Zhou Y; Li S; Li Y; Liao W
    J Cell Biochem; 2019 Mar; 120(3):2816-2827. PubMed ID: 28865121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A.
    Hoskins JW; Jia J; Flandez M; Parikh H; Xiao W; Collins I; Emmanuel MA; Ibrahim A; Powell J; Zhang L; Malats N; Bamlet WR; Petersen GM; Real FX; Amundadottir LT
    Carcinogenesis; 2014 Dec; 35(12):2670-8. PubMed ID: 25233928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma.
    Janky R; Binda MM; Allemeersch J; Van den Broeck A; Govaere O; Swinnen JV; Roskams T; Aerts S; Topal B
    BMC Cancer; 2016 Aug; 16():632. PubMed ID: 27520560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.
    Wu Y; Liu H; Shi X; Yao Y; Yang W; Song Y
    Oncotarget; 2015 Apr; 6(11):9160-72. PubMed ID: 25863539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
    Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
    Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
    Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
    Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology and clinical applications of pancreatic cancer stem cells.
    Abel EV; Simeone DM
    Gastroenterology; 2013 Jun; 144(6):1241-8. PubMed ID: 23622133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX9 inhibits β-TrCP-mediated protein degradation to promote nuclear GLI1 expression and cancer stem cell properties.
    Deng W; Vanderbilt DB; Lin CC; Martin KH; Brundage KM; Ruppert JM
    J Cell Sci; 2015 Mar; 128(6):1123-38. PubMed ID: 25632159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin-Notch signaling axis is involved in pancreatic cancer progression.
    Harbuzariu A; Rampoldi A; Daley-Brown DS; Candelaria P; Harmon TL; Lipsey CC; Beech DJ; Quarshie A; Ilies GO; Gonzalez-Perez RR
    Oncotarget; 2017 Jan; 8(5):7740-7752. PubMed ID: 27999190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
    Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
    Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin protects against dominant negative-HNF1A-induced apoptosis in INS-1 cells.
    Farrelly AM; Kilbride SM; Bonner C; Prehn JH; Byrne MM
    Apoptosis; 2011 Nov; 16(11):1128-37. PubMed ID: 21874357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
    Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
    Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA HNF1A-AS is upregulated and promotes cell proliferation and metastasis in nasopharyngeal carcinoma.
    Zhuang K; Wu Q; Jin CS; Yuan HJ; Cheng JZ
    Cancer Biomark; 2016; 16(2):291-300. PubMed ID: 26756620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells.
    Rybak AP; Tang D
    Cell Signal; 2013 Dec; 25(12):2734-42. PubMed ID: 24036214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells.
    Recio-Boiles A; Ilmer M; Rhea PR; Kettlun C; Heinemann ML; Ruetering J; Vykoukal J; Alt E
    Oncotarget; 2016 Mar; 7(9):9890-906. PubMed ID: 26840266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.